Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Trends from 1999 to 2007 in the surgical treatments of kidney cancer in Europe: data from the Veneto Region, Italy.

Fedeli U, Novara G, Alba N, Ficarra V, Artibani W, Spolaore P.

BJU Int. 2010 May;105(9):1255-9. doi: 10.1111/j.1464-410X.2009.08929.x. Epub 2009 Oct 10.

3.

Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.

Gratzke C, Seitz M, Bayrle F, Schlenker B, Bastian PJ, Haseke N, Bader M, Tilki D, Roosen A, Karl A, Reich O, Khoder WY, Wyler S, Stief CG, Staehler M, Bachmann A.

BJU Int. 2009 Aug;104(4):470-5. doi: 10.1111/j.1464-410X.2009.08439.x. Epub 2009 Feb 23.

4.

Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.

Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI.

Urology. 2010 Feb;75(2):271-5. doi: 10.1016/j.urology.2009.04.098. Epub 2009 Dec 4.

PMID:
19962740
5.
6.

Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.

Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG.

BJU Int. 2007 Dec;100(6):1235-9.

7.

A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project).

Schiavina R, Mari A, Antonelli A, Bertolo R, Bianchi G, Borghesi M, Brunocilla E, Fiori C, Longo N, Martorana G, Mirone V, Morgia G, Novara G, Porpiglia F, Rovereto B, Serni S, Simeone C, Sodano M, Terrone C, Carini M, Minervini A.

Eur J Surg Oncol. 2015 Mar;41(3):346-52. doi: 10.1016/j.ejso.2014.12.001. Epub 2014 Dec 27.

PMID:
25583459
8.

Trends in nephron-sparing surgery for renal neoplasia.

Bhayani SB, Belani JS, Hidalgo J, Figenshau RS, Landman J, Venkatesh R, Kibel AS.

Urology. 2006 Oct;68(4):732-6.

PMID:
17070343
9.

Trends in the use of of nephron-sparing surgery (NSS) at an Australian tertiary referral centre: an analysis of surgical decision-making using the R.E.N.A.L. nephrometry scoring system.

Satasivam P, Rajarubendra N, Chia PH, Munshey A, Sengupta S, Bolton D.

BJU Int. 2012 May;109(9):1341-4. doi: 10.1111/j.1464-410X.2011.10595.x. Epub 2011 Sep 27.

10.

Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.

Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stöckle M.

Eur Urol. 2006 Feb;49(2):308-13. Epub 2005 Dec 9.

PMID:
16359779
11.

A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Marechal JM, Klotz L, Skinner E, Keane T, Claessens I, Sylvester R; European Organization for Research and Treatment of Cancer (EORTC); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Southwest Oncology Group (SWOG); Eastern Cooperative Oncology Group (ECOG).

Eur Urol. 2007 Jun;51(6):1606-15. Epub 2006 Nov 15.

PMID:
17140723
12.

Laparoscopic and partial nephrectomy.

Novick AC.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6322S-7S. Review.

13.

Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.

Ghavamian R, Cheville JC, Lohse CM, Weaver AL, Zincke H, Blute ML.

J Urol. 2002 Aug;168(2):454-9.

PMID:
12131287
14.

Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2004 Mar;171(3):1066-70.

PMID:
14767272
15.

A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.

Heuer R, Gill IS, Guazzoni G, Kirkali Z, Marberger M, Richie JP, de la Rosette JJ.

Eur Urol. 2010 Feb;57(2):223-32. doi: 10.1016/j.eururo.2009.10.023. Epub 2009 Oct 20. Review.

PMID:
19853989
16.

Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.

Pahernik S, Cudovic D, Roos F, Melchior SW, Thüroff JW.

BJU Int. 2007 Jul;100(1):26-9.

17.

Quality of life after surgery for localized renal cell carcinoma: comparison between radical nephrectomy and nephron-sparing surgery.

Poulakis V, Witzsch U, de Vries R, Moeckel M, Becht E.

Urology. 2003 Nov;62(5):814-20.

PMID:
14624900
18.

Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.

Patard JJ, Pantuck AJ, Crepel M, Lam JS, Bellec L, Albouy B, Lopes D, Bernhard JC, Guillé F, Lacroix B, De La Taille A, Salomon L, Pfister C, Soulié M, Tostain J, Ferriere JM, Abbou CC, Colombel M, Belldegrun AS.

Eur Urol. 2007 Jul;52(1):148-54. Epub 2007 Jan 16.

PMID:
17240036
19.

Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy.

Malcolm JB, Bagrodia A, Derweesh IH, Mehrazin R, Diblasio CJ, Wake RW, Wan JY, Patterson AL.

BJU Int. 2009 Aug;104(4):476-81. doi: 10.1111/j.1464-410X.2009.08376.x. Epub 2009 Feb 10.

20.

Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.

Krambeck A, Iwaszko M, Leibovich B, Cheville J, Frank I, Blute M.

BJU Int. 2008 Jun;101(11):1375-9. doi: 10.1111/j.1464-410X.2008.07588.x.

Supplemental Content

Support Center